Merck KGaA and GSK Terminate their ~$4.2B Collaboration Due to Clinical Failures
Shots: The companies terminated their collaboration that centered around bintrafusp alfa as the drug failed to show potential in [email protected] Lung 037 study as the 2L treatment for metastatic BTC The termination followed a decision made by the two companies to discontinue the development of bintrafusp alfa as a 1L therapy for patients with stage […]